APO Research
Talk to an analyst

APO RESEARCH · REPORT

Femoral Cannula

Femoral arteriovenous cannula provides temporary support for extracorporeal circulation and gas exchange to replace heart or lung function as a bridge for resuscitation or other long-term support.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Femoral arteriovenous cannula provides temporary support for extracorporeal circulation and gas exchange to replace heart or lung function as a bridge for resuscitation or other long-term support.

When intubated through the femoral and internal jugular veins, blood is drawn through the femoral or internal jugular vein catheter and pumped through membrane oxygenators to remove carbon dioxide, increase oxygen, and provide temperature control.

Partial to complete extracorporeal lung support is provided to maintain adequate oxygenation and normal blood flow.

Selected research

Market Outlook & Growth Opportunities

Global Femoral Cannula Market Outlook and Growth Opportunities 2026

31 December 2025194 pages

Choose your research edition.

Industry ResearchFemoral Cannula Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Femoral Cannula Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Femoral Cannula Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Femoral Cannula Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Femoral Cannula Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Femoral arteriovenous cannula provides temporary support for extracorporeal circulation and gas exchange to replace heart or lung function as a bridge for resuscitation or other long-term support.

When intubated through the femoral and internal jugular veins, blood is drawn through the femoral or internal jugular vein catheter and pumped through membrane oxygenators to remove carbon dioxide, increase oxygen, and provide temperature control.

Partial to complete extracorporeal lung support is provided to maintain adequate oxygenation and normal blood flow.

Read the full market overview

Globally, major manufacturers of femoral arteriovenous systems include Medtronic, Edward Lifescience, LivaNova, Surge Cardiovascular, Kangxin, Xenios AG, and Chalice Medical.

The main producers are mainly in Europe and the United States.

This report provides an overview of the global Femoral Cannula market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Femoral Cannula and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Femoral Cannula sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Femoral Cannula market size, projected growth trends, production technologies, key applications, and end-use industries.

Femoral Cannula Segment by Company

Medtronic

Edward Lifescience

LivaNova

Surge Cardiovascular

Changzhou KangXin Medical Instruments Co., Ltd.

Chalice Medical Ltd.

Xenios AG

Femoral Cannula Segment by Type

Unipolar

Bipolar

Femoral Cannula Segment by Application

Traditional extracorporeal circulation surgery

Extracorporeal membrane oxygenation (ECMO)

Hemodialysis

Other

Femoral Cannula Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Femoral Cannula status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Femoral Cannula market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Femoral Cannula significant trends, drivers, influence factors in global and regions.

6. To analyze Femoral Cannula competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Femoral Cannula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Femoral Cannula and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Femoral Cannula.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Femoral Cannula market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Femoral Cannula industry.

Chapter 3: Detailed analysis of Femoral Cannula manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Femoral Cannula in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Femoral Cannula in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Femoral Cannula Industry Trends Table 2. Femoral Cannula Industry Drivers Table 3. Femoral Cannula Industry Opportunities and Challenges Table 4. Femoral Cannula Industry Restraints Table 5. Global Femoral Cannula Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Femoral Cannula Revenue Share by Company (2021-2026) Table 7. Global Femoral Cannula Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Femoral Cannula Sales Volume Share by Company (2021-2026) Table 9. Global Femoral Cannula Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Femoral Cannula Company Ranking, (2024-2026) & (USD Million) Table 11. Global Femoral Cannula Key Company Manufacturing Base & Headquarters Table 12. Global Femoral Cannula Company, Product Type & Application Table 13. Global Femoral Cannula Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Femoral Cannula by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Unipolar Table 18. Significant Companies of Bipolar Table 19. Global Femoral Cannula Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Femoral Cannula Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Femoral Cannula Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Femoral Cannula Sales Volume Share by Type (2021-2026) Table 23. Global Femoral Cannula Sales Volume Share by Type (2027-2032) Table 24. Global Femoral Cannula Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Femoral Cannula Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Femoral Cannula Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Femoral Cannula Sales Value Share by Type (2021-2026) Table 28. Global Femoral Cannula Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Traditional extracorporeal circulation surgery Table 30. Significant Companies of Extracorporeal membrane oxygenation (ECMO) Table 31. Significant Companies of Hemodialysis Table 32. Significant Companies of Other Table 33. Global Femoral Cannula Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Femoral Cannula Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Femoral Cannula Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Femoral Cannula Sales Volume Share by Application (2021-2026) Table 37. Global Femoral Cannula Sales Volume Share by Application (2027-2032) Table 38. Global Femoral Cannula Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Femoral Cannula Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Femoral Cannula Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Femoral Cannula Sales Value Share by Application (2021-2026) Table 42. Global Femoral Cannula Sales Value Share by Application (2027-2032) Table 43. Global Femoral Cannula Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Femoral Cannula Sales by Region (2021-2026) & (K Units) Table 45. Global Femoral Cannula Sales Market Share by Region (2021-2026) Table 46. Global Femoral Cannula Sales by Region (2027-2032) & (K Units) Table 47. Global Femoral Cannula Sales Market Share by Region (2027-2032) Table 48. Global Femoral Cannula Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Femoral Cannula Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Femoral Cannula Sales Value Share by Region (2021-2026) Table 51. Global Femoral Cannula Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Femoral Cannula Sales Value Share by Region (2027-2032) Table 53. Global Femoral Cannula Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Femoral Cannula Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Femoral Cannula Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Femoral Cannula Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Femoral Cannula Sales by Country (2021-2026) & (K Units) Table 58. Global Femoral Cannula Sales Market Share by Country (2021-2026) Table 59. Global Femoral Cannula Sales by Country (2027-2032) & (K Units) Table 60. Global Femoral Cannula Sales Market Share by Country (2027-2032) Table 61. Global Femoral Cannula Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Femoral Cannula Sales Value Market Share by Country (2021-2026) Table 63. Global Femoral Cannula Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Femoral Cannula Sales Value Market Share by Country (2027-2032) Table 65. Medtronic Company Information Table 66. Medtronic Business Overview Table 67. Medtronic Femoral Cannula Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Medtronic Femoral Cannula Product Portfolio Table 69. Medtronic Recent Development Table 70. Edward Lifescience Company Information Table 71. Edward Lifescience Business Overview Table 72. Edward Lifescience Femoral Cannula Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Edward Lifescience Femoral Cannula Product Portfolio Table 74. Edward Lifescience Recent Development Table 75. LivaNova Company Information Table 76. LivaNova Business Overview Table 77. LivaNova Femoral Cannula Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. LivaNova Femoral Cannula Product Portfolio Table 79. LivaNova Recent Development Table 80. Surge Cardiovascular Company Information Table 81. Surge Cardiovascular Business Overview Table 82. Surge Cardiovascular Femoral Cannula Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Surge Cardiovascular Femoral Cannula Product Portfolio Table 84. Surge Cardiovascular Recent Development Table 85. Changzhou KangXin Medical Instruments Co., Ltd. Company Information Table 86. Changzhou KangXin Medical Instruments Co., Ltd. Business Overview Table 87. Changzhou KangXin Medical Instruments Co., Ltd. Femoral Cannula Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Changzhou KangXin Medical Instruments Co., Ltd. Femoral Cannula Product Portfolio Table 89. Changzhou KangXin Medical Instruments Co., Ltd. Recent Development Table 90. Chalice Medical Ltd. Company Information Table 91. Chalice Medical Ltd. Business Overview Table 92. Chalice Medical Ltd. Femoral Cannula Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Chalice Medical Ltd. Femoral Cannula Product Portfolio Table 94. Chalice Medical Ltd. Recent Development Table 95. Xenios AG Company Information Table 96. Xenios AG Business Overview Table 97. Xenios AG Femoral Cannula Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Xenios AG Femoral Cannula Product Portfolio Table 99. Xenios AG Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Femoral Cannula Distributors List Table 103. Femoral Cannula Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Femoral Cannula Product Image Figure 2. Global Femoral Cannula Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Femoral Cannula Sales Value (2021-2032) & (US$ Million) Figure 4. Global Femoral Cannula Sales (2021-2032) & (K Units) Figure 5. Global Femoral Cannula Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Femoral Cannula Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Unipolar Image Figure 10. Bipolar Image Figure 11. Global Femoral Cannula Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Femoral Cannula Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Femoral Cannula Sales Volume Share by Type (2021-2032) Figure 14. Global Femoral Cannula Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Femoral Cannula Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Femoral Cannula Sales Value Share by Type (2021-2032) Figure 17. Traditional extracorporeal circulation surgery Image Figure 18. Extracorporeal membrane oxygenation (ECMO) Image Figure 19. Hemodialysis Image Figure 20. Other Image Figure 21. Global Femoral Cannula Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Femoral Cannula Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Femoral Cannula Sales Volume Share by Application (2021-2032) Figure 24. Global Femoral Cannula Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Femoral Cannula Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Femoral Cannula Sales Value Share by Application (2021-2032) Figure 27. Global Femoral Cannula Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Femoral Cannula Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Femoral Cannula Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Femoral Cannula Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Femoral Cannula Sales Value (2021-2032) & (US$ Million) Figure 32. North America Femoral Cannula Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Femoral Cannula Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Femoral Cannula Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Femoral Cannula Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Femoral Cannula Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Femoral Cannula Sales Value (2021-2032) & (US$ Million) Figure 38. South America Femoral Cannula Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Femoral Cannula Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Femoral Cannula Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Femoral Cannula Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Femoral Cannula Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Femoral Cannula Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Femoral Cannula Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Femoral Cannula Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Unipolar
  • Bipolar
Applications
  • Traditional extracorporeal circulation surgery
  • Extracorporeal membrane oxygenation (ECMO)
  • Hemodialysis
  • Other
Companies covered
  • Medtronic
  • Edward Lifescience
  • LivaNova
  • Surge Cardiovascular
  • Changzhou KangXin Medical Instruments Co., Ltd.
  • Chalice Medical Ltd.
  • Xenios AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Femoral Cannula Sales Value (2021-2032)
  4. 1.2.2 Global Femoral Cannula Sales Volume (2021-2032)
  5. 1.2.3 Global Femoral Cannula Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Femoral Cannula Market Dynamics
  1. 2.1 Femoral Cannula Industry Trends
  2. 2.2 Femoral Cannula Industry Drivers
  3. 2.3 Femoral Cannula Industry Opportunities and Challenges
  4. 2.4 Femoral Cannula Industry Restraints
3 Femoral Cannula Market by Company
  1. 3.1 Global Femoral Cannula Company Revenue Ranking in 2025
  2. 3.2 Global Femoral Cannula Revenue by Company (2021-2026)
  3. 3.3 Global Femoral Cannula Sales Volume by Company (2021-2026)
  4. 3.4 Global Femoral Cannula Average Price by Company (2021-2026)
  5. 3.5 Global Femoral Cannula Company Ranking (2024-2026)
  6. 3.6 Global Femoral Cannula Company Manufacturing Base and Headquarters
  7. 3.7 Global Femoral Cannula Company Product Type and Application
  8. 3.8 Global Femoral Cannula Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Femoral Cannula Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Femoral Cannula Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Femoral Cannula Market by Type
  1. 4.1 Femoral Cannula Type Introduction
  2. 4.1.1 Unipolar
  3. 4.1.2 Bipolar
  4. 4.2 Global Femoral Cannula Sales Volume by Type
  5. 4.2.1 Global Femoral Cannula Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Femoral Cannula Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Femoral Cannula Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Femoral Cannula Sales Value by Type
  9. 4.3.1 Global Femoral Cannula Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Femoral Cannula Sales Value by Type (2021-2032)
  11. 4.3.3 Global Femoral Cannula Sales Value Share by Type (2021-2032)
5 Femoral Cannula Market by Application
  1. 5.1 Femoral Cannula Application Introduction
  2. 5.1.1 Traditional extracorporeal circulation surgery
  3. 5.1.2 Extracorporeal membrane oxygenation (ECMO)
  4. 5.1.3 Hemodialysis
  5. 5.1.4 Other
  6. 5.2 Global Femoral Cannula Sales Volume by Application
  7. 5.2.1 Global Femoral Cannula Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Femoral Cannula Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Femoral Cannula Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Femoral Cannula Sales Value by Application
  11. 5.3.1 Global Femoral Cannula Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Femoral Cannula Sales Value by Application (2021-2032)
  13. 5.3.3 Global Femoral Cannula Sales Value Share by Application (2021-2032)
6 Femoral Cannula Regional Sales and Value Analysis
  1. 6.1 Global Femoral Cannula Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Femoral Cannula Sales by Region (2021-2032)
  3. 6.2.1 Global Femoral Cannula Sales by Region: 2021-2026
  4. 6.2.2 Global Femoral Cannula Sales by Region (2027-2032)
  5. 6.3 Global Femoral Cannula Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Femoral Cannula Sales Value by Region (2021-2032)
  7. 6.4.1 Global Femoral Cannula Sales Value by Region: 2021-2026
  8. 6.4.2 Global Femoral Cannula Sales Value by Region (2027-2032)
  9. 6.5 Global Femoral Cannula Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Femoral Cannula Sales Value (2021-2032)
  12. 6.6.2 North America Femoral Cannula Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Femoral Cannula Sales Value (2021-2032)
  15. 6.7.2 Europe Femoral Cannula Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Femoral Cannula Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Femoral Cannula Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Femoral Cannula Sales Value (2021-2032)
  21. 6.9.2 South America Femoral Cannula Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Femoral Cannula Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Femoral Cannula Sales Value Share by Country, 2025 VS 2032
7 Femoral Cannula Country-level Sales and Value Analysis
  1. 7.1 Global Femoral Cannula Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Femoral Cannula Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Femoral Cannula Sales by Country (2021-2032)
  4. 7.3.1 Global Femoral Cannula Sales by Country (2021-2026)
  5. 7.3.2 Global Femoral Cannula Sales by Country (2027-2032)
  6. 7.4 Global Femoral Cannula Sales Value by Country (2021-2032)
  7. 7.4.1 Global Femoral Cannula Sales Value by Country (2021-2026)
  8. 7.4.2 Global Femoral Cannula Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Femoral Cannula Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Femoral Cannula Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Femoral Cannula Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Femoral Cannula Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Femoral Cannula Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Femoral Cannula Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Femoral Cannula Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Femoral Cannula Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Femoral Cannula Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Femoral Cannula Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Femoral Cannula Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Femoral Cannula Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Femoral Cannula Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Femoral Cannula Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Femoral Cannula Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Femoral Cannula Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Femoral Cannula Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Femoral Cannula Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Femoral Cannula Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Femoral Cannula Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Femoral Cannula Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Femoral Cannula Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Femoral Cannula Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Femoral Cannula Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Femoral Cannula Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Femoral Cannula Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Femoral Cannula Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Femoral Cannula Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Femoral Cannula Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Femoral Cannula Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Femoral Cannula Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Femoral Cannula Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Femoral Cannula Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Edward Lifescience
  8. 8.2.1 Edward Lifescience Company Information
  9. 8.2.2 Edward Lifescience Business Overview
  10. 8.2.3 Edward Lifescience Femoral Cannula Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Edward Lifescience Femoral Cannula Product Portfolio
  12. 8.2.5 Edward Lifescience Recent Developments
  13. 8.3 LivaNova
  14. 8.3.1 LivaNova Company Information
  15. 8.3.2 LivaNova Business Overview
  16. 8.3.3 LivaNova Femoral Cannula Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 LivaNova Femoral Cannula Product Portfolio
  18. 8.3.5 LivaNova Recent Developments
  19. 8.4 Surge Cardiovascular
  20. 8.4.1 Surge Cardiovascular Company Information
  21. 8.4.2 Surge Cardiovascular Business Overview
  22. 8.4.3 Surge Cardiovascular Femoral Cannula Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Surge Cardiovascular Femoral Cannula Product Portfolio
  24. 8.4.5 Surge Cardiovascular Recent Developments
  25. 8.5 Changzhou KangXin Medical Instruments Co., Ltd.
  26. 8.5.1 Changzhou KangXin Medical Instruments Co., Ltd. Company Information
  27. 8.5.2 Changzhou KangXin Medical Instruments Co., Ltd. Business Overview
  28. 8.5.3 Changzhou KangXin Medical Instruments Co., Ltd. Femoral Cannula Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Changzhou KangXin Medical Instruments Co., Ltd. Femoral Cannula Product Portfolio
  30. 8.5.5 Changzhou KangXin Medical Instruments Co., Ltd. Recent Developments
  31. 8.6 Chalice Medical Ltd.
  32. 8.6.1 Chalice Medical Ltd. Company Information
  33. 8.6.2 Chalice Medical Ltd. Business Overview
  34. 8.6.3 Chalice Medical Ltd. Femoral Cannula Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Chalice Medical Ltd. Femoral Cannula Product Portfolio
  36. 8.6.5 Chalice Medical Ltd. Recent Developments
  37. 8.7 Xenios AG
  38. 8.7.1 Xenios AG Company Information
  39. 8.7.2 Xenios AG Business Overview
  40. 8.7.3 Xenios AG Femoral Cannula Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Xenios AG Femoral Cannula Product Portfolio
  42. 8.7.5 Xenios AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Femoral Cannula Value Chain Analysis
  2. 9.1.1 Femoral Cannula Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Femoral Cannula Sales Mode & Process
  6. 9.2 Femoral Cannula Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Femoral Cannula Distributors
  9. 9.2.3 Femoral Cannula Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst